Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses

Published:2011-08 Issue:8 Volume:63 Page:2445-2455
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Hou Li-Fei,He Shi-Jun,Li Xin,Yang Yang,He Pei-Lan,Zhou Yu,Zhu Feng-Hua,Yang Yi-Fu,Li Ying,Tang Wei,Zuo Jian-Ping

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.30392/fullpdf

Reference41 articles.

1. Murine models of systemic lupus erythematosus;Theofilopoulos;Adv Immunol,1985

2. Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice;Reilly;Immunol Res,2002

3. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice;Jevnikar;J Exp Med,1994

4. Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4- CD8- double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice;Merino;J Autoimmun,1995

5. Plasticity of CD4+ T cell lineage differentiation;Zhou;Immunity,2009

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal stem cells-derived extracellular vesicles ameliorate lupus nephritis by regulating T and B cell responses;Stem Cell Research & Therapy;2024-07-18

2. Artemisinin and its derivatives as promising therapies for autoimmune diseases;Heliyon;2024-04

3. Network pharmacology-based strategy to investigate the mechanisms of artemisinin in treating primary Sjögren’s syndrome;BMC Immunology;2024-02-12

4. Th1-related transcription factors and cytokines in systemic lupus erythematosus;Frontiers in Immunology;2023-12-18

5. Artemisinins: Promising drug candidates for the treatment of autoimmune diseases;Medicinal Research Reviews;2023-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3